Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Here’s an 11% Dividend Stock That Pays Out Monthlyhttps://www.fool.ca/2026/08/12/heres-an-11-dividend-stock-that-pays-out-monthly/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=243d03cb-6812-4e4c-8f53-f3d1768d0ad8
This Canadian dividend stock pays investors every month and yields close to 11%. Here's what's behind the payout and the risk.
Via The Motley Fool · August 12, 2026
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcriptfool.com
Revenue surged 82% year-over-year as hospital adoption doubled to 20 sites.
Via The Motley Fool · August 12, 2026
CoreWeave Has $104 Billion of Contracted Revenue and a $59 Billion Market Valuefool.com
The market can see the demand just fine. The discount is about what delivering it will cost.
Via The Motley Fool · August 12, 2026
Which Precious Metals ETF Is the Better Buy: iShares' Gold Trust IAU or Silver Miners SLVP?fool.com
Gold offers lower costs and stability, while mining equities deliver higher returns with greater volatility. Which suits your portfolio?
Via The Motley Fool · August 12, 2026
Enbridge or Suncor? Here’s the Dividend Stock I’d Rather Ownhttps://www.fool.ca/2026/08/12/enbridge-or-suncor-heres-the-dividend-stock-id-rather-own-2/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=a4802013-0979-4fda-b9dd-34e4594d1869
Let’s assess Enbridge and Suncor Energy to determine a better buy for income-seeking investors.
Via The Motley Fool · August 12, 2026
WhiteFiber (WYFI) Q2 2026 Earnings Call Transcriptfool.com
CEO Tabar discusses $28.8M revenue growth and major GPU deployment agreements.
Via The Motley Fool · August 12, 2026
Why Nebius Stock Skyrocketed Todayfool.com
Demand for artificial intelligence computing capacity is rising exponentially, according to CEO Arkady Volozh.
Via The Motley Fool · August 12, 2026
I’d Invest $7,000 in This Tech Stock Before the AI Boom Hits Canadahttps://www.fool.ca/2026/08/12/id-invest-7000-in-this-tech-stock-before-the-ai-boom-hits-canada-3/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=683b3c94-d4a5-43f2-8442-dcd4c23a7037
Canada’s AI boom may be less about flashy startups and more about the unglamorous companies helping businesses adopt AI safely.
Via The Motley Fool · August 12, 2026
Clover Health (CLOV) Q2 2026 Earnings Call Transcriptfool.com
Medicare Advantage membership surged 48% as profitability improved sharply.
Via The Motley Fool · August 12, 2026
Veeco (VECO) Q2 2026 Earnings Call Transcriptfool.com
AI demand for advanced packaging and laser annealing drove $193.5M revenue.
Via The Motley Fool · August 12, 2026
Arcus Biosciences (RCUS) Q2 2026 Earnings Call Transcriptfool.com
CEO Rosen targets casdatifan as $5B to $10B drug with no frontline competition.
Via The Motley Fool · August 12, 2026
NuScale Power (SMR) Q2 2026 Earnings Call Transcriptfool.com
CEO Hopkins discusses shift toward commercial readiness and $1.9 billion liquidity boost.
Via The Motley Fool · August 12, 2026
Solaris Energy Infrastructure (SEI) Q2 2026 Earnings Call Transcriptfool.com
Revenue hit $219 million as power solutions surged 23% sequentially.
Via The Motley Fool · August 12, 2026
Riley Exploration Permian (REPX) Q2 2026 Earnings Call Transcriptfool.com
Oil production surged 5% sequentially amid raised capex guidance.
Via The Motley Fool · August 12, 2026
HMH (HMH) Q2 2026 Earnings Call Transcriptfool.com
Margins expanded despite revenue decline as service orders surged 50% year over year.
Via The Motley Fool · August 12, 2026
Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ?fool.com
RSPH levels the playing field across 60 established healthcare names while IBBQ bets on more than 250 biotech companies at a lower cost.
Via The Motley Fool · August 12, 2026
OptimizeRx Q2 Earnings Call Highlightsmarketbeat.com
OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its earnings call. The company reaffirmed its full-year revenue outlook of $95 million to $100 million and
Via MarketBeat · August 12, 2026
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platformmarketbeat.com
Carlsmed (NASDAQ:CARL) outlined its strategy for expanding its personalized spine-surgery platform, citing clinical data, reimbursement changes and a planned cervical product launch as potential drivers of growth during a Bank of America small- and mid-cap virtual event. Chief Executive Officer Mik
Via MarketBeat · August 12, 2026
Marchex Q2 Earnings Call Highlightsmarketbeat.com
Marchex (NASDAQ:MCHX) reported second-quarter revenue of $11 million, up from $10.6 million in the first quarter, as new sales and customer upsells contributed to growth. The company also outlined its post-acquisition strategy following the July 1 closing of its purchase of Archenia, which managemen
Via MarketBeat · August 12, 2026
MaxCyte Q2 Earnings Call Highlightsmarketbeat.com
MaxCyte (NASDAQ:MXCT) reported second-quarter 2026 revenue of $7.3 million, down 15% from $8.5 million a year earlier, as lower license revenue, timing of instrument placements and prior-year processing assembly purchases affected results. Management said the quarter came in ahead of its expectation
Via MarketBeat · August 12, 2026
Nano Nuclear Energy Q3 Earnings Call Highlightsmarketbeat.com
Nano Nuclear Energy (NASDAQ:NNE) said its third-quarter progress centered on advancing the licensing and engineering of its Kronos microreactor, expanding its nuclear fuel-cycle capabilities through acquisitions, and pursuing potential commercial deployments for data centers, industrial users and go
Via MarketBeat · August 12, 2026
Omeros Q2 Earnings Call Highlightsmarketbeat.com
Omeros (NASDAQ:OMER) reported second-quarter net sales of $28.5 million for YARTEMLEA, its newly launched treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, as the company generated positive operating cash flow and reduced its convertible debt after th
Via MarketBeat · August 12, 2026
Lumexa Imaging Q2 Earnings Call Highlightsmarketbeat.com
Lumexa Imaging (NASDAQ:LMRI) reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance. Chief Executive Officer Caitlin Zulla said the
Via MarketBeat · August 12, 2026
Lulu's Fashion Lounge Q2 Earnings Call Highlightsmarketbeat.com
Lulu's Fashion Lounge (NASDAQ:LVLU) reported second-quarter fiscal 2026 revenue of $67.8 million, down 17% from a year earlier, as lower order volume and higher return rates weighed on sales. The company said it continued to prioritize merchandise assortment changes, inventory discipline and operati
Via MarketBeat · August 12, 2026
Liftoff Mobile Q2 Earnings Call Highlightsmarketbeat.com
Liftoff Mobile (NASDAQ:LFTO) reported second-quarter revenue growth and expanded adjusted EBITDA margins in its first earnings call as a public company, citing demand across the app economy, continued machine-learning improvements and activity tied to the FIFA World Cup. Revenue rose 7% sequentiall
Via MarketBeat · August 12, 2026